Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
2024 · New England Journal of Medicine · 98 citations
https://doi.org/10.1056/nejmoa2313812
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
127
Citations
3
h-index
2
i10-index
Yongxian Hu is an academic researcher from First Affiliated Hospital Zhejiang University. The author has contributed to research in topics: CAR-T cell therapy research & Virus-based gene therapy research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 3, co-authored 6 publications.
https://doi.org/10.1056/nejmoa2313812
https://doi.org/10.1186/s12879-024-09893-x
https://doi.org/10.1007/s00277-025-06399-7
Click to start Chat